Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation Elektif olarak stent yerleştirilen hastalarda klopidogrel tedavisi sırasında yüksek trombosit reaktivitesi ile karaciğer yağlanması arasında ilişki


VELİBEY Y., Tekkeşin A. İ., Barutca H., YILDIRIMTÜRK Ö., BOZBEYOĞLU E., Çakıllı Y., ...Daha Fazla

Turk Kardiyoloji Dernegi Arsivi, cilt.46, sa.5, ss.349-357, 2018 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 5
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5543/tkda.2018.67817
  • Dergi Adı: Turk Kardiyoloji Dernegi Arsivi
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.349-357
  • Anahtar Kelimeler: Coronary artery disease, Hepatosteatosis, High on-clopidogrel platelet reactivity, Percutaneous coronary intervention
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objective: The present study is an investigation of the association between high on-treatment platelet reactivity to clopidogrel (HTPRC) and hepatosteatosis in patients who had elective stent implantation due to coronary artery disease. Methods: A total of 190 consecutive patients who underwent an elective coronary stent implantation due to coronary artery disease were prospectively enrolled in the study. Eligible patients were given a 300 mg loading dose of clopidogrel before percutaneous coronary intervention. All of the patients underwent an ultrasound assessment for fatty liver. The patients were divided into 2 groups according to the detection of HTPRC: patients with HTPRC and patients without HTPRC. Results: HTPRC was present in 54.2% (103 of 190 patients) of the total study population. The age and body mass index data were similar between the 2 groups. In all, 111 (58.6%) patients had hepatosteatosis. The HTPRC ratio was statistically higher in female patients (p=0.032). Hepatosteatosis was significantly greater in patients with HTPRC (p<0.001); 84 (81.6%) patients with HTPRC had hepatosteatosis (p=0.001). There was also a statistically significant association between the hepatosteatosis grade and HTPRC (p<0.001). The percentage of HTPRC was greater in patients with ≥grade 2 hepatosteatosis than grade 1 (p<0.001). Logistic regression analysis indicated that hepatosteatosis (odds ratio: 9.403, 95% confidence interval: 4.519-19.566; p<0.001), fasting blood glucose, and hypertension were independent predictors of HTPRC. Conclusion: To the best of our knowledge, this is the first study to demonstrate a relationship between hepatosteatosis and HTPRC.